KOVALTRY Trademark

Trademark Overview

On Thursday, May 16, 2013, a trademark application was filed for KOVALTRY with the United States Patent and Trademark Office. The USPTO has given the KOVALTRY trademark a serial number of 85933959. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 8, 2020. This trademark is owned by Bayer Intellectual Property GmbH. The KOVALTRY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hemophilia
kovaltry

General Information

Serial Number85933959
Word MarkKOVALTRY
Filing DateThursday, May 16, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 8, 2020
Registration Number4558634
Registration DateTuesday, July 1, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hemophilia
Translation of Words in MarkThe word(s) "KOVALTRY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 24, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Intellectual Property GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMonheim am Rhein 40789
DE
Party NameBayer Intellectual Property GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMonheim am Rhein 40789
DE
Party NameBayer Intellectual Property GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMonheim am Rhein 40789
DE

Trademark Events

Event DateEvent Description
Thursday, January 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 20, 2013NEW APPLICATION ENTERED
Friday, May 24, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 4, 2013ASSIGNED TO EXAMINER
Monday, September 9, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 9, 2013NON-FINAL ACTION WRITTEN
Monday, September 9, 2013NON-FINAL ACTION E-MAILED
Wednesday, December 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 6, 2014ASSIGNED TO LIE
Thursday, January 9, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 28, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 24, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 25, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, March 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 7, 2014TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, May 7, 2014NOTICE OF ALLOWANCE CANCELLED
Wednesday, May 28, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, July 1, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, February 14, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 14, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 18, 2020TEAS SECTION 8 & 15 RECEIVED
Friday, September 4, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 8, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 8, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 1, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 11, 2024TEAS SECTION 8 & 9 RECEIVED

Related Keywords

kovaltry hemophilia treatment preparations pharmaceutical